Clinical Trials Browser

Terminated × Pancreatic Neoplasms × Pioglitazone × Clear all

NCT00867126 2018-11-26

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Pancreatic Neoplasms